cartilage oligomeric matrix protein
1. Normal Function
The COMP gene provides the instructions for making the COMP protein. This protein is found in the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells. Specifically, the COMP protein is located in the extracellular matrix surrounding the cells that make up ligaments and tendons, and near cartilage-forming cells (chondrocytes). Chondrocytes play an important role in bone formation (osteogenesis). In the bones of the spine, hips, and limbs, the process of osteogenesis starts with the formation of cartilage, which is then converted into bone.
The normal function of the COMP protein is not fully known. It is believed to play a role in cell growth and division (proliferation) and the self-destruction of cells (apoptosis), as well as in the regulation of cell movement and attachment. Research has also shown that the COMP protein binds strongly to calcium.
2. Health Conditions Related to Genetic Changes
2.1. Multiple Epiphyseal Dysplasia
More than 20 mutations in the COMP gene that cause dominant multiple epiphyseal dysplasia have been identified. This disorder can also be caused by mutations in four other genes; however, the majority of individuals have mutations in the COMP gene.
Mutations in the COMP gene that cause dominant multiple epiphyseal dysplasia change one protein building block (amino acid) or result in small additions or deletions of amino acids in the COMP protein. All identified mutations have occurred in two regions of the COMP protein, which are referred to as the type III and C-terminal domains. COMP mutations lead to the improper folding of the COMP protein in the endoplasmic reticulum, a structure in the cell involved in protein processing and transport. The abnormal COMP protein is unable to leave the endoplasmic reticulum, which causes this cellular structure to enlarge. The endoplasmic reticulum eventually becomes so large that it is no longer able to function normally, and the chondrocyte dies. The premature death of chondrocytes results in diminished growth of the long bones and short stature.
Researchers believe that the lack of COMP protein in the spaces between the chondrocytes leads to the formation of abnormal cartilage. This abnormal cartilage probably breaks down easily, which results in early-onset osteoarthritis.
About 60 mutations in the COMP gene have been identified in individuals with pseudoachondroplasia. One particular mutation is found in approximately 30 percent of affected individuals. This mutation results in the deletion of a single amino acid, called aspartic acid, in the COMP protein. This gene mutation is usually written as 469delD or D469del. Most other COMP gene mutations involve the substitution of one amino acid for another amino acid in the COMP protein.
Mutations in the COMP gene that cause pseudoachondroplasia also result in the buildup of COMP protein in the endoplasmic reticulum and eventual chondrocyte death. It is not clear why some mutations in the COMP gene cause pseudoachondroplasia and other mutations cause dominant multiple epiphyseal dysplasia.
3. Other Names for This Gene
- cartilage oligomeric matrix protein (pseudoachondroplasia, epiphyseal dysplasia 1, multiple)
- pseudoachondroplasia (epiphyseal dysplasia 1, multiple)
The entry is from https://medlineplus.gov/genetics/gene/comp
- Briggs MD, Chapman KL. Pseudoachondroplasia and multiple epiphyseal dysplasia:mutation review, molecular interactions, and genotype to phenotype correlations. Hum Mutat. 2002 May;19(5):465-78. Review.
- Chen TL, Posey KL, Hecht JT, Vertel BM. COMP mutations: domain-dependentrelationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes. J Cell Biochem. 2008 Feb 15;103(3):778-87.
- Developmental Biology (sixth edition, 2000): Osteogenesis: The Development of Bones
- Gagarina V, Carlberg AL, Pereira-Mouries L, Hall DJ. Cartilage oligomericmatrix protein protects cells against death by elevating members of the IAPfamily of survival proteins. J Biol Chem. 2008 Jan 4;283(1):648-59.
- Hecht JT, Makitie O, Hayes E, Haynes R, Susic M, Montufar-Solis D, Duke PJ,Cole WG. Chondrocyte cell death and intracellular distribution of COMP and typeIX collagen in the pseudoachondroplasia growth plate. J Orthop Res. 2004Jul;22(4):759-67.
- Jakkula E, Mäkitie O, Czarny-Ratajczak M, Jackson GC, Damignani R, Susic M,Briggs MD, Cole WG, Ala-Kokko L. Mutations in the known genes are not the majorcause of MED; distinctive phenotypic entities among patients with no identifiedmutations. Eur J Hum Genet. 2005 Mar;13(3):292-301. Erratum in: Eur J Hum Genet. 2005 Oct;13(10):1166. Czarny-Ratacjzak, Malwina [corrected to Czarny-Ratajczak,Malwina].
- Posey KL, Yang Y, Veerisetty AC, Sharan SK, Hecht JT. Model systems forstudying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci.2008 Mar;65(5):687-99. doi: 10.1007/s00018-007-7485-0. Review.
- Zankl A, Jackson GC, Crettol LM, Taylor J, Elles R, Mortier GR, Spranger J,Zabel B, Unger S, Merrer ML, Cormier-Daire V, Hall CM, Wright MJ, Bonafe L,Superti-Furga A, Briggs MD. Preselection of cases through expert clinical andradiological review significantly increases mutation detection rate in multipleepiphyseal dysplasia. Eur J Hum Genet. 2007 Feb;15(2):150-4.